{"data":{"id":"us-mi/mich.-comp.-laws-550.1416a","jurisdiction":"us-mi","citation":"Mich. Comp. Laws § 550.1416a","heading":"Coverage for drug used in antineoplastic therapy and cost of its administration; conditions.","body":"Sec. 416a.\n\nA health care corporation shall provide coverage in each group and nongroup certificate for a federal food and drug administration approved drug used in antineoplastic therapy and the reasonable cost of its administration. Coverage shall be provided regardless of whether the specific neoplasm for which the drug is being used as treatment is the specific neoplasm for which the drug has received approval by the federal food and drug administration if all of the following conditions are met:\n\nThe drug is ordered by a physician for the treatment of a specific type of neoplasm.\n\nThe drug is approved by the federal food and drug administration for use in antineoplastic therapy.\n\nThe drug is used as part of an antineoplastic drug regimen.\n\nCurrent medical literature substantiates its efficacy and recognized oncology organizations generally accept the treatment.\n\nThe physician has obtained informed consent from the patient for the treatment regimen which includes federal food and drug administration approved drugs for off-label indications.","path":["MI Code","Chapter 550","Act Act-350-of-1980"],"source_url":"https://www.legislature.mi.gov/Laws/MCL?objectName=mcl-550-1416a","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:31Z","sha256":"7a736b38ff94749e6b3d466090751e9591c4542898511afbc7902d9ca813b74d","source_id":"us-mi","stale":false,"prev":"us-mi/mich.-comp.-laws-550.1416","next":"us-mi/mich.-comp.-laws-550.1416b"},"notice":"GroundRules: Original legal text. Not legal advice."}